From Land to Sea: Modalis Ltd Explores the Evolution of the Sea Freight Industry in An Exclusive Interview

Multiple factors affect the decision to choose a particular mode of transport for pharmaceuticals. Listening to the feedback received on the topic of air freight vs sea freight, SMi Group interviewed Managing Director for Modalis Ltd, Mark Edwards, to gain insight on his thoughts on the continuing importance of sea freight in the transportation of temperature controlled pharmaceuticals. Here's a snippet:

SMi: How would you describe the sea freight distribution industry segment at the moment, and how do you see it evolving over the next few years?

Mark: "...Shipping lines have woken up to the fact that they can earn significant revenues from moving pharmaceuticals but that they need special handling. Some have invested heavily in smart solutions in order to facilitate the transportation of pharma by sea. I see other lines playing catch-up. I also see the introduction of more technology giving visibility to the process and increasing the confidence of this mode to be effective for pharmaceuticals..."

SMi: What do you believe are the biggest challenges faced at each stage in the distribution process and what can be done to overcome these challenges?

Mark: "...I think that traceability throughout the supply chain is the industry’s biggest challenge. My hope is that the “Internet of things” can offer some practical and cost-effective solutions in the near future..."

The full Q&A is now available to view in the download centre on the event website.

Mark will be discussing real life experiences of companies successfully using sea freight on Day 1 of the conference, with a focus on switching to sea freight. Mark will also be a panelist during the interactive GDP guideline compliance panel discussion together with Tony Wright, CEO, Exelsius (Moderator), Stephen Mitchell, Quality Lead Logistics Partnerships, GSK, Glyn Stacey, CEO Bio Ltd and Executive Director, International Stem Cell Banking Initiative & Sascha Sonnenberg, VP Commercial Operations Americas & EMEA, Marken.

More information can be found on the event website.

For those interested in attending the two-day conference, there is currently a £100 early bird discount for registrations made before Tuesday 31st October 2017.

Cold Chain Distribution 2017 is sponsored by Marken (Lead Sponsor), Berlinger & Co., Emball'iso, Peli BioThermal, Sensitech, TP3 Global, Topa Thermal, World Courier & Yourway Transport

12th Cold Chain Distribution Conference and Exhibition
13th – 14th December 2017
London, UK
www.coldchain-distribution.com/OPENPR
Follow the conversation on Twitter and LinkedIn at #ColdChainSMi

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

1 Westminister Bridge Road

This release was published on openPR.